tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:HCM Stock Latest News

HUTCHMED Sets March 5 Board Meeting to Approve 2025 Annual Results
Company AnnouncementsHUTCHMED Sets March 5 Board Meeting to Approve 2025 Annual Results
19d ago
Hutchmed reports publication of SACHI results in The Lancet
PremiumThe Fly
Hutchmed reports publication of SACHI results in The Lancet
1M ago
AZN
HCM
HUTCHMED’s Savolitinib Combo Shows Phase III Success in EGFR-Mutated Lung Cancer
PremiumCompany Announcements
HUTCHMED’s Savolitinib Combo Shows Phase III Success in EGFR-Mutated Lung Cancer
1M ago
HUTCHMED’s Sovleplenib Hits Phase III Goal in Warm Autoimmune Hemolytic Anemia Trial in China
PremiumCompany Announcements
HUTCHMED’s Sovleplenib Hits Phase III Goal in Warm Autoimmune Hemolytic Anemia Trial in China
2M ago
Hutchmed says Phase III of ESLIM-02 trial met primary endpoint
PremiumThe Fly
Hutchmed says Phase III of ESLIM-02 trial met primary endpoint
2M ago
HCM
Hutchmed price target lowered to $22 from $25 at BofA
PremiumThe FlyHutchmed price target lowered to $22 from $25 at BofA
2M ago
HCM
Hutchmed initiates Phase III stage of Phase II/III trial
Premium
The Fly
Hutchmed initiates Phase III stage of Phase II/III trial
2M ago
HCM
Hutchmed initiates Phase III stage of Phase II/III trial
Premium
The Fly
Hutchmed initiates Phase III stage of Phase II/III trial
2M ago
HCM
HUTCHMED Advances Surufatinib Combo into Phase III Trial for Metastatic Pancreatic Cancer in China
PremiumCompany Announcements
HUTCHMED Advances Surufatinib Combo into Phase III Trial for Metastatic Pancreatic Cancer in China
2M ago
HUTCHMED Confirms Total Voting Rights and Share Capital as of Year-End 2025
PremiumCompany Announcements
HUTCHMED Confirms Total Voting Rights and Share Capital as of Year-End 2025
2M ago
Hutchmed announces savolitinib new drug application acceptance in China
PremiumThe Fly
Hutchmed announces savolitinib new drug application acceptance in China
2M ago
HCM
HUTCHMED Wins Priority Review in China for Savolitinib in MET‑Amplified Gastric Cancer
PremiumCompany Announcements
HUTCHMED Wins Priority Review in China for Savolitinib in MET‑Amplified Gastric Cancer
2M ago
Hutchmed announces fanregratinib NDA acceptance in China with priority review
PremiumThe FlyHutchmed announces fanregratinib NDA acceptance in China with priority review
2M ago
HCM
HUTCHMED Wins Priority Review in China for Fanregratinib in Second-Line Liver Cancer
Premium
Company Announcements
HUTCHMED Wins Priority Review in China for Fanregratinib in Second-Line Liver Cancer
2M ago
HUTCHMED Launches Global Clinical Trials for Innovative Cancer Therapy
Premium
Company Announcements
HUTCHMED Launches Global Clinical Trials for Innovative Cancer Therapy
2M ago
Hutchmed announces contract renewal with the China NHSA
PremiumThe Fly
Hutchmed announces contract renewal with the China NHSA
3M ago
HCM
HUTCHMED Expands Drug Coverage in China’s National and Commercial Insurance Lists
PremiumCompany Announcements
HUTCHMED Expands Drug Coverage in China’s National and Commercial Insurance Lists
3M ago
HUTCHMED Announces Total Voting Rights and Share Structure Update
PremiumCompany Announcements
HUTCHMED Announces Total Voting Rights and Share Structure Update
3M ago
HUTCHMED to Present New Clinical Data at 2025 ESMO and ASH Meetings
PremiumCompany Announcements
HUTCHMED to Present New Clinical Data at 2025 ESMO and ASH Meetings
3M ago
Hutchmed completes enrollment of SAFFRON Phase 3 trial of Orpathys+Tagrisso
PremiumThe FlyHutchmed completes enrollment of SAFFRON Phase 3 trial of Orpathys+Tagrisso
4M ago
HCM
HUTCHMED Completes Enrollment for Key Lung Cancer Trial
Premium
Company Announcements
HUTCHMED Completes Enrollment for Key Lung Cancer Trial
4M ago
Hutchmed highlights pipeline, business progress at R&D Updates event
Premium
The Fly
Hutchmed highlights pipeline, business progress at R&D Updates event
4M ago
HCM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >